Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Breast cancer treatment Stories

2012-10-23 21:04:57

The breast cancer treatment brachytherapy–heralded for its low complication rates–actually results in more complications than whole-breast radiation one year after treatment, Yale School of Medicine researchers report in the October issue of the Journal of Clinical Oncology. The standard treatment for older women with early stage breast cancer includes breast-conserving surgery, typically followed by radiation therapy to reduce the risk of breast cancer recurrence. Rather than...

2012-10-23 07:28:13

SAN DIEGO, Oct. 23, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapies to treat solid tumor cancers, announced positive preliminary results from a Phase II multicenter trial investigating the use of ImmunoPulse in Merkel cell carcinoma (MCC) patients at the 27th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2012). The data suggest that ImmunoPulse, which locally delivers...

Genetic Tumor Testing Aids Breast Cancer Treatment
2012-10-21 09:45:26

redOrbit staff & Wire Reports — Your Universe Online Experts at the Baylor College of Medicine (BCM) have started using a new DNA sequencing technique they say will help devise individualized, more effective methods of treating breast cancer. According to oncologists at the BCM Lester and Sue Smith Breast Center, the methods used to treat a patient's cancer are dependent upon several factors, including the size of the tumor, its biological state, the stage the illness is...

2012-10-03 02:27:53

MADISON, Wis., Oct. 3, 2012 /PRNewswire/ -- Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that an oral presentation on research conducted by Jamey Weichert, Ph.D., Lance Hall, M.D., Anne M. Traynor, M.D., Glenn Liu, M.D. and their colleagues is being made by Dr. Weichert at the Imaging in 2020 Conference taking place September 30 to October 4, 2012 in Jackson Hole, Wyoming. This...

2012-10-01 14:25:24

Two new studies presented at the ESMO 2012 Congress in Vienna, Austria show how improvements in breast cancer treatments are making it possible for more women to conserve their breasts following therapy, but raise concerns about whether enough women are being offered these approaches. Prof Michael Gnant, a surgical oncologist from Vienna's Medical University, who was not involved in the studies, commented: "Clearly, advances in interdisciplinary preoperative approaches have contributed to...

2012-09-28 02:24:46

REDWOOD CITY, Calif., and VIENNA, Sept. 28, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of data that support expanded use of the Oncotype DX® tests in optimizing treatment decisions for breast and colon cancer patients at various stages of disease. The new data confirm the ability of the Oncotype DX colon cancer test to predict recurrence risk in stage II and stage III colon cancer patients, and exploratory analyses have identified 16 genes...

2012-09-26 14:21:09

CTCA at Midwestern is the only Illinois hospital to receive this high honor for providing quality care for breast cancer patients CHICAGO, Sept. 26, 2012 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center (Midwestern) has been recognized by the National Quality Measures for Breast Centers Program (NQMBC) as being among the top centers in the country for providing quality breast cancer care. The CTCA at Midwestern breast center is...

2012-09-20 11:34:26

Films that feature characters with cancer have become a familiar sight for movie-goers in recent years, but they rarely portray the patient's chances of survival accurately, Italian researchers will report at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna, Austria. After carefully studying 82 movies that center on a person with cancer, from Cat on a Hot Tin Roof, and Gran Torino to Diary of a Country Priest and beyond, Dr Luciano De Fiore from Sapienza...

2012-09-20 02:28:52

BETHESDA, Md., Sept. 20, 2012 /PRNewswire/ -- Northwest Biotherapeutics (OTC.BB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for cancer, announced today that it is in late stage discussions with medical centers in the U.S. and Europe to proceed with a Phase I/II clinical trial with the Company's third major product line, DCVax(®)-Direct, for all types of solid tumor cancers (i.e., cancers in any tissues). The Company previously received FDA...

2012-09-19 23:03:42

A new study published in The Oncologist found that genetically engineered mouse models appear to be the most accurate preclinical predictor of how cancer-fighting drugs are delivered to melanoma patients. The study, led by UNC-Chapel Hill researchers along with colleagues in the Research Triangle Park, Pittsburgh and Austria, tested how four different types of mouse models predict the delivery of carboplatin, a commonly used anticancer drug, to melanoma tumors in patients. Durham, NC (PRWEB)...